Life Sciences Market Research Reports

Latin America presents many opportunities for the infectious diseases market. This market insight offers an overview of the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well...

More than 100 companies participate in the global next generation sequencing (NGS) informatics market. This research service evaluates the market from 2012 to 2018. The research covers key market drivers and restraints, analysis of the changing competitive landscape, revenue forecasts, and the important trends that affect market growth. Also includ...

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house NGS technology use is expected to increase within the next 12 months. Data accuracy and operating costs are the top criteria for purchasing sequencing instruments. Disease-r...

This research service provides a complete analysis of the opportunities and trends for the Indian medical devices market. It quantifies the market size, provides insight into the burdens of diseases in India, and examines market dynamics from 2011 to 2018. It provides an in-depth analysis of the competitive environment by highlighting the markets c...

This issue of Vital Signs published June 30, 2013, provides a global overview of market trends and expected growth of the Point-of-care Testing (POCT) market.

This outlook analyzes trends and revenue in the global medical imaging equipment market from 2012 to 2017. The market is segmented by geographic region and by medical imaging modality, with 10 regional and 7 modality segments evaluated. The modalities evaluated are general X-ray, mammographic X-ray, interventional X-ray, CT, ultrasound, MR, and mol...

This research service evaluates the global mass spectrometry market from 2010 to 2017. Regions analyzed include the US, Europe, Asia-Pacific (APAC), and Rest of World (ROW) combined. Technology segments analyzed include single quadrupole LC/MS, tandem LC/MS, time-of-flight LC/MS, and MALDI-TOF-MS. The mature market remains dynamic due to a technolo...

This issue of Vital Signs, released on June 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.